N/A
N=187
Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation
Type 2 Diabetes Mellitus · Colonoscopy
Bottom Line
View on ClinicalTrials.gov: NCT03109951 ↗Enrolled (actual)
187
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcome: Primary: Abnormal Glucose Levels After Colonoscopic Preparation — 2; 0; 185 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Colonoscopy preparation using polyethylene glycol (Drug)
- Age
- Adult, Older Adult · 20+ yrs
- Sex
- All
- Sponsor
- Catholic Kwandong University
- Primary completion
- Dec 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Abnormal Glucose Levels After Colonoscopic Preparation |
2; 0; 185 | — |
| SECONDARY Cognition of Hypoglycemic Symptoms |
96 | — |
| SECONDARY Number of Participants With Self-treatment and Relief of Hypoglycemic Symptoms |
4 | — |
Summary
Type 2 diabetes is rapidly increasing globally and has been associated with an increased risk of colorectal cancer. Therefore, the numbers of diabetic patients who will undergo colonoscopic screening are expected to grow exponentially. Colonoscopic preparation entails prolonged fasting, cessation of anti-diabetic medication and ingestion of preparation medications. This may put the diabetic patient at risk of potentially dangerous hypo- or hyperglycemia. However, studies regarding the safety of colonoscopic preparation in diabetic are lacking. In this study, the investigators aim to discover the prevalence of abnormal glucose levels in diabetic patients who undergo colonoscopy. The investigators also aim to find out risk factors for abnormal glucose levels and develop a safe preparation protocol.
Eligibility Criteria
Inclusion Criteria
- Type 2 diabetes
- Between ages of 20-75
- Undergo colonoscopy at International St. Mary's Hospital
Exclusion Criteria
- Type 1 diabetes patients
- Did not undergo colonoscopy preparation
- Did not meet fasting requirements
- Have known current infectious diseases
- Have known cancer and/or are under cancer treatment
- Are under intravenous fluid therapy during colonoscopy
Data sourced from ClinicalTrials.gov (NCT03109951). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.